Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Biomarker-guided Implementation of Glutamine to Reduce the Occurence of AKI After Cardiac Surgery

NCT04019184 is registered in ClinicalTrials.gov with University Hospital Muenster as lead sponsor.

NCT NCT04019184
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04019184 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Biomarker-guided Implementation of Glutamine to Reduce the Occurence of AKI After Cardiac Surgery
Lead sponsor
University Hospital Muenster
Phase
Phase 3
Overall status
Completed
Start date
July 18, 2019
Completion date
May 13, 2020
Enrollment
64 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute kidney injury, cardiac surgery